Ancient origin of the CTH alelle carrying the c.200C>T (p.T67I) variant in patients with cystathioninuria.
Hereditary cystathioninuria is due to mutations in the CTH gene that encodes for cystathionase, a pyridoxal-5'-phosphate (PLP) dependent enzyme. To date, mutations in this gene have been described in 10 unrelated cystathioninuric patients. Enzyme assays have showed that mutated cystathionase exhibits lower activity than controls. As cystathioninuria is usually accompanied by a wide variety of symptoms, it has been questioned whether it is a disease or just a biochemical finding not associated with the clinical picture of these patients. This is the first report of Spanish patients with cystathioninuria and mild to severe neurological symptoms in childhood. After oral pyridoxine therapy biochemical parameters have normalized but clinical amelioration was not evident. All patients were homozygotes for the c.200C>T (p.T67I) variant which is the most prevalent inactivating mutation in the CTH gene. To further investigate the history of the alleles carrying the c.200C>T transition in Europe, we also constructed the haplotypes on the CTH locus in our Spanish patients as well as in a clinical series of cystathioninuric patients from the Czech Republic harboring the same nucleotide change. We suggest that the CTH p.T67I substitution could have an ancient common origin, which probably occurred in the Neolithic Era and spread throughout Europe.
Espinós
C
C
CIBERER BIOBANK, CIBER de Enfermedades Raras (CIBERER), Valencia, Spain. cespinos@ibv.csic.es
García-Cazorla
A
A
Martínez-Rubio
D
D
Martínez-Martínez
E
E
Vilaseca
M A
MA
Pérez-Dueñas
B
B
Kožich
V
V
Palau
F
F
Artuch
R
R
D000483:Alleles; D002648:Child; D002675:Child, Preschool; D003542:Cystathionine gamma-Lyase / Q000235:genetics*; D018153:Czech Republic; D005060:Europe; D005260:Female; D014644:Genetic Variation / Q000235:genetics*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000235:genetics
D003542:Cystathionine gamma-Lyase